Document is current
Any future updates will be listed below
-
Authors
Yamato, Masaya
Kinoshita, Masahiro https://orcid.org/0009-0007-1789-3641
Yoshida, Yuki
Yamamoto, Yudai
Izuhara, Rie
Sonoyama, Takuhiro
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000056047 at UMIN JapanDocuments that mention this clinical trial
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study
https://doi.org/10.1007/s40121-025-01156-9
-
Funding
Funding for this research was provided by:
Shionogi & Co., Ltd.
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 3 April 2025
First Online: 19 April 2025
Declarations
:
: Masaya Yamato has received lecture fees from, and serves as an advisor for, Shionogi & Co., Ltd. Masahiro Kinoshita, Yuki Yoshida, and Takuhiro Sonoyama are employees of Shionogi & Co., Ltd.. Yudai Yamamoto and Rie Izuhara have no conflicts of interest to disclose.
: The study was conducted in accordance with the Declaration of Helsinki, and the Ethical Guidelines for Life Sciences and Medical Research Involving Human Subjects. The research protocol was reviewed and approved by the Rinku General Medical Center Clinical Research Ethics Committee (2-23 Rinku Ourai-Kita, Izumisano, Osaka 598-8577, Japan; protocol ID 2024FY-I-003; date of approval 20 August 2024). Patient consent was acquired using an opt-out procedure and no data were included that would allow identification of individual patients.
